Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2153 Views
-
Last post by frodo
-
- 0 Replies
- 9885 Views
-
Last post by NHE
-
- 2 Replies
- 1639 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1832 Views
-
Last post by Petr75
-
- 0 Replies
- 1211 Views
-
Last post by NHE
-
- 2 Replies
- 1863 Views
-
Last post by frodo
-
- 0 Replies
- 10738 Views
-
Last post by NHE
-
- 0 Replies
- 2491 Views
-
Last post by frodo
-
- 0 Replies
- 2625 Views
-
Last post by NHE